Mitsubishi Tanabe Pharma reports the discovery and characterization of novel SGLT2 inhibitors Sep. 12, 2013
Aegerion obtains orphan drug designation in Japan for use of lomitapide in treatment of HoFH Sep. 10, 2013
Diurnal completes pharmacokinetic portion of CATCH trial in congenital adrenal hyperplasia Sep. 9, 2013
Preclinical evaluation of a mixed-mirror image DNA/RNA aptamer to regulate glucose tolerance Sep. 9, 2013